Drug for Lou Gehrig’s Disease Pulled from Market

  • 📰 FCN2go
  • ⏱ Reading Time:
  • 9 sec. here
  • 8 min. at publisher
  • 📊 Quality Score:
  • News: 28%
  • Publisher: 51%

Health News

Drug,Lou Gehrig’S Disease,Amylyx Pharmaceuticals

Amylyx Pharmaceuticals will no longer sell a drug for Lou Gehrig’s disease as it did not prove effective. Patients already taking the therapy can continue to receive it for free.

The maker of a drug for Lou Gehrig’s disease recently announced that it will pull the medicine from the market as it did not help patients with the condition. Amylyx Pharmaceuticals will halt sales and marketing of the drug in the U.

S. and Canada, and new patients will no longer be able to get a prescription. However, patients already taking the therapy can enroll in a program to receive it for free.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 523. in BUSİNESS

Business Business Latest News, Business Business Headlines